2025 · 1st Quarter (Jan 1 - Mar 31)

IONIS PHARMACEUTICAL, INC.

Filed by FORBES-TATE.

Open official filing

Source-reported fields

Filing overview

Type: 1st Quarter - Report
Posted: Apr 15, 2025
Income: $30,000.00
Expenses: Not reported
Registrant: FORBES-TATE
Client: IONIS PHARMACEUTICAL, INC.
Filing UUID: b7eb2d04-b057-4f73-a206-9322e32eb658
Termination date: Not reported

Literal source text

Lobbying issues and bill citations

HCR · Health Issues

Issues related to Creating Hope Act and issues related to H.R. 5547/S. 476 - Maintaining Investments in New Innovation.

Literal federal measure citations: H.R. 5547, S. 476

MMM · Medicare/Medicaid

Issues related to Creating Hope Act & issues related to H.R. 5547/S. 476 - Maintaining Investment in New Innovation.

Literal federal measure citations: H.R. 5547, S. 476

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.